Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

被引:32
|
作者
Tramper-Stranders, G. A. [1 ]
van der Ent, C. K. [1 ]
Molin, S. [2 ]
Yang, L. [2 ]
Hansen, S. K. [2 ]
Rau, M. H. [2 ]
Ciofu, O. [3 ]
Johansen, H. K. [4 ,5 ]
Wolfs, T. F. W. [6 ]
机构
[1] Wilhelmina Childrens Hosp, Cyst Fibrosis Ctr, Univ Med Ctr Utrecht, Dept Paediat Resp Med, NL-3508 AB Utrecht, Netherlands
[2] Tech Univ Denmark, Infect Microbiol Grp, Ctr Syst Biol, DK-2800 Lyngby, Denmark
[3] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Danish CF Ctr, DK-2100 Copenhagen, Denmark
[6] Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands
关键词
Chronic infection; cystic fibrosis; genotyping; Pseudomonas aeruginosa; virulence; III SECRETION; PULMONARY INFECTIONS; GENETIC ADAPTATION; DCTA GENE; COLONIZATION; VIRULENCE; STRAINS; MICROEVOLUTION; INACTIVATION; PATHOGEN;
D O I
10.1111/j.1469-0691.2011.03627.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2012; 18: 567574 Abstract Despite intensive eradication therapy, some CF patients with early Pseudomonas aeruginosa infection rapidly develop a chronic infection. To elucidate factors associated with this persistence, bacterial characteristics of early P. aeruginosa isolates were analysed that were either eradicated rapidly or persisted despite multiple antimicrobial treatments. Eighty-six early infection episodes were studied. First P. aeruginosa isolates from patients with eradication (36) or persistent infection (16) were included; isolates from patients with intermittent infection (34) were omitted from the study. Virulence assays, antimicrobial resistance, cytotoxicity and mutation frequencies were analysed in vitro. P. aeruginosa was genotyped by SNP-array. Transcriptomic profiles of two eradicated and two persistent strains were compared. Nineteen per cent of patients developed persistent infection; 42% achieved eradication. Secretion of virulence factors and mutation frequencies were highly variable among both eradicated and persistent isolates and were not different between the groups. Cytotoxicity was present in 57% of eradicated vs. 100% of persistent isolates (p <0.01). None of the isolates were resistant to antibiotics. The isolates were genotypically highly diverse. Multivariate analysis showed that in vitro determined bacterial characteristics could not predict persistence after first P. aeruginosa infection. Preliminary transcriptomic data showed increased expression of some genes related to a metabolic pathway. The early onset of chronic infection was not associated with (in vitro determined) bacterial characteristics only. Although the persistent isolates were more often cytotoxic, for the individual patient it was not possible to predict the risk of persistence based on bacterial characteristics. Unknown factors such as host-pathogen and pathogen-pathogen interactions should be further explored.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [1] Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Qin, Xuan
    Zhou, Chuan
    Zerr, Danielle M.
    Adler, Amanda
    Addetia, Amin
    Yuan, Shuhua
    Greninger, Alexander L.
    MSPHERE, 2018, 3 (02)
  • [2] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [3] Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Artini, Marco
    Vrenna, Gianluca
    Trecca, Marika
    Assanti, Vanessa Tuccio Guarna
    Fiscarelli, Ersilia Vita
    Papa, Rosanna
    Selan, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [4] Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis
    Troxler, Robert Bradley
    Hoover, Wynton C.
    Britton, LaCrecia J.
    Gerwin, Andrea M.
    Rowe, Steven M.
    PEDIATRIC PULMONOLOGY, 2012, 47 (11) : 1113 - 1122
  • [5] Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Doering, Gerd
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 300 (08) : 573 - 577
  • [6] Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis
    Giugno, Hilda
    Castanos, Claudio
    Lubatti, Alberto
    Luis Pinheiro, Jose
    Hernandez, Claudia
    Gonzalez Pena, Hebe
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2010, 108 (02): : 141 - 147
  • [7] Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
    Staudinger, Benjamin J.
    Muller, Jocelyn Fraga
    Halldorsson, Skarpheoinn
    Boles, Blaise
    Angermeyer, Angus
    Dao Nguyen
    Rosen, Henry
    Baldursson, Olafur
    Gottfreosson, Magnus
    Guomundsson, Guomundur Hrafn
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (07) : 812 - 824
  • [8] Can Mucoid Pseudomonas aeruginosa Be Eradicated in Children With Cystic Fibrosis?
    McPherson, Helen
    Rosenthal, Mark
    Bush, Andrew
    PEDIATRIC PULMONOLOGY, 2010, 45 (06) : 566 - 568
  • [9] COMPARISON OF THE WORLDWIDE TRANSMISSIBLE PSEUDOMONAS AERUGINOSA WITH ISOLATES FROM BRAZILIAN CYSTIC FIBROSIS PATIENTS
    Leao, Robson Souza
    Carvalho-Assef, Ana Paula D.
    Ferreira, Alex Guerra
    Folescu, Tania Wrobel
    Barth, Afonso Luis
    Pitt, Tyrone Leslie
    Marques, Elizabeth Andrade
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2010, 41 (04) : 1079 - 1081
  • [10] Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis
    Heltshe, S. L.
    Khan, U.
    Beckett, V.
    Baines, A.
    Emerson, J.
    Sanders, D. B.
    Gibson, R. L.
    Morgan, W.
    Rosenfeld, M.
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (03) : 341 - 347